ACS Chemical Neuroscience Molecule Spotlight on Telcagepant (MK-0974)

被引：3
|
作者：
Hopkins, Corey R. [1 ,2 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA
来源：
ACS CHEMICAL NEUROSCIENCE | 2011年 / 2卷 / 07期
关键词：
MIGRAINE; HEADACHE; EFFICACY;
D O I：
10.1021/cn200059f
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Telcagepant (MK-0974) is a novel calcitonin gene-related peptide (CGRP) receptor antagonise currently undergoing clinical trials for migraine (http://www.merck.com/research/pipeline/home.html). MK-0974 is currently being studied in phase III clinical trials.
引用
收藏
页码：334 / 335
页数：2
相关论文
共 50 条
  • [41] MK-0974 oral CGRP antagonist inhibits capsaicin-induced increase in dermal microvascular blood flow
    Sinclair, S. R.
    Kane, S. A.
    Xiao, A.
    Willson, K. J.
    Xu, Y.
    Hickey, L.
    Palcza, J.
    de Lepeleire, I.
    Vanmolkot, F. H. M.
    de Hoon, J. N. J. M.
    Murphy, M. G.
    NEUROLOGY, 2007, 68 (12) : A307 - A307
  • [42] 治疗偏头痛的降钙素基因相关肽拮抗剂——MK-0974
    药学进展, 2009, 33 (05) : 232 - 234
  • [43] Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
    Ho, Tony W.
    Ferrari, Michel D.
    Dodick, David W.
    Galet, Vince
    Kost, James
    Fan, Xiaoyin
    Leibensperger, Heather
    Froman, Samar
    Assaid, Christopher
    Lines, Christopher
    Koppen, Hille
    Winner, Paul K.
    LANCET, 2008, 372 (9656): : 2115 - 2123
  • [44] ACS Chemical Neuroscience in 2014
    Lindsley, Craig W.
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (02): : 81 - 81
  • [45] Discovery of MK-0974: A potent, orally bioavailable calcitonin gene-related peptide (CGRP) receptor antagonist for the treatment of migraine
    Paone, Daniel V.
    Shaw, Anthony
    Nguyen, Diem
    Burgey, Chris
    Deng, James
    Stump, Craig
    Quigley, Amy
    DeSolms, Jane
    Kane, Stefanie
    Koblan, Ken
    Bednar, Rodney
    Mallee, John
    Mosser, Scott
    Salvatore, Chris
    McMasters, Daniel
    Hershey, Jim
    Corcoran, Halea
    Lyle, Betsy
    Wong, Brad
    Roller, Shane
    Miller-Stein, Cindy
    Rowe, Janice
    Yu, Sean
    Graham, Sam
    Vacca, Joseph
    Williams, Theresa
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 549 - 549
  • [46] Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry
    Xu, Yang
    Willson, Kenneth J.
    Anderson, Melanie D. G.
    Musson, Donald G.
    Miller-Stein, Cynthia M.
    Woolf, Eric J.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (16-17): : 1634 - 1642
  • [47] Acute antimigraine efficacy and tolerability of the novel oral CGRP receptor antagonist MK-0974: A phase III clinical trial versus placebo and zolmitriptan
    Ho, T. W.
    Ferrari, M. D.
    Dodick, D. W.
    Galet, V
    Kost, P.
    Fan, X.
    Leibensperger, H.
    Froman, S.
    Assaid, C.
    Koppen, H.
    Winner, P.
    HEADACHE, 2008, 48 : S7 - S8
  • [48] Jacob Hooker to lead ACS Chemical Neuroscience
    Taylor, Alexandra
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (40) : 35 - 35
  • [49] ACS Chemical Neuroscience in 2012: Opportunities and Challenges
    Lindsley, Craig
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (01): : 1 - 1
  • [50] Synthesis of the (3R,6S)-3-amino-6-(2,3-difluorophenyl)azepan-2-one of telcagepant (MK-0974), a calcitonin gene-related peptide receptor antagonist for the treatment of migraine headache
    Burgey, Christopher S.
    Paone, Daniel V.
    Shaw, Anthony W.
    Deng, James Z.
    Nguyen, Diem N.
    Potteiger, Craig M.
    Graham, Samuel L.
    Vacca, Joseph P.
    Williams, Theresa M.
    ORGANIC LETTERS, 2008, 10 (15) : 3235 - 3238
12345